What it sells
AI-driven Parkinson's treatment preparing for Phase III
Business model breakdown
Economics: what it saves and how it charges
Pharma-style: regulated as drug-SaMD combination product and reimbursed like pharma.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-08-12 | Series A | $36M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.